Physician profile
Jon C Parks
NPI 1477544658
$10,144.74
in general payments reported to CMS, 2019-2025
33 companies · $681 in 2025
The $681 reported for 2025 was more than what a typical Pain Medicine provider received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,322 · 2020: $1,036 · 2021: $2,228 · 2022: $1,511 · 2023: $1,294 · 2024: $1,073 · 2025: $681.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,048.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,048.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,504.00 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Kyphon Express II Kyphopak Tray |
| Medtronic USA, INC. | $2,398.42 | 2019-2020 | |
| Nalu Medical, INC. | $1,771.75 | 2021-2024 | Nalu Neurostimulation System |
| Collegium Pharmaceutical, INC. | $755.79 | 2019-2025 | Xtampza, Belbuca |
| Amgen INC. | $477.39 | 2019-2022 | |
| Spr Therapeutics, INC | $363.72 | 2023-2025 | Sprint Pns System |
| Pfizer INC. | $203.98 | 2019-2023 | |
| Arbor Pharmaceuticals, INC. | $148.18 | 2019-2021 | |
| Si-Bone, INC. | $138.73 | 2021-2025 | |
| Saol Therapeutics INC. | $130.98 | 2020-2022 | |
| Spinal Simplicity, LLC | $115.96 | 2021 | |
| Boston Scientific Corporation | $98.23 | 2020-2024 | |
| Curonix LLC | $97.95 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Abbott Laboratories | $97.52 | 2020-2023 | Proclaim |
| Novartis Pharmaceuticals Corporation | $87.16 | 2019-2021 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $77.32 | 2024-2025 | |
| Almatica Pharma LLC | $76.64 | 2021 | |
| Lilly USA, LLC | $75.49 | 2019-2021 | |
| Ge Healthcare | $64.28 | 2020 | |
| Horizon Therapeutics Plc | $61.69 | 2020-2022 | |
| Amneal Pharmaceuticals LLC | $60.00 | 2022 | |
| Redhill Biopharma INC. | $50.55 | 2020 | |
| Relievant Medsystems, INC. | $37.68 | 2021 | |
| Biodelivery Sciences International, INC. | $37.07 | 2021 | |
| Vertos Medical, INC. | $36.14 | 2021-2024 | Mild Device Kit |
| Ibsa Pharma INC. | $33.74 | 2023 | Tirosint, Licart |
| Abbvie INC. | $33.39 | 2022-2024 | |
| Virtus Pharmaceuticals LLC | $28.42 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $25.02 | 2019 | |
| Kyowa Kirin, INC. | $17.77 | 2024 | Crysvita |
| Protega Pharmaceutials INC | $15.52 | 2025 | Roxybond |
| Zyla Life Sciences, INC. | $13.00 | 2019 | |
| Grt US Holding, INC. | $11.26 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jon Parks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.